Approches de population et modélisation en pharmacologie = Population approach and modeling in pharmacologyURIEN, S.La Lettre du pharmacologue (Boulogne). 2002, Vol 16, Num 3, pp 79-81, issn 0984-452XArticle

Paclitaxel (Taxol®) : mécanismes d'action et optimisation thérapeutique par administration hebdomadaire = Paclitaxel (Taxol) : mecanisms of action and therapeutical optimisation by weekly administrationURIEN, S.La Lettre du pharmacologue (Boulogne). 2001, Vol 15, Num 1-2, pp 15-21, issn 0984-452XArticle

MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processesURIEN, S.Pharmaceutical research. 1995, Vol 12, Num 8, pp 1225-1230, issn 0724-8741Article

SERUM PROTEIN BINDING OF VALPROIC ACID IN HEALTHY SUBJECTS AND IN PATIENTS WITH LIVER DISEASEURIEN S; ALBENGRES E; TILLEMENT JP et al.1981; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1981; VOL. 19; NO 7; PP. 319-325; BIBL. 1 P.Article

Effets stimulants respiratoires de l'acétazolamide en réanimation : METABOLISME ET NUTRITION = Respiratory stimulant effects of acetazolamide in the intensive care unit : METABOLISM AND NUTRITIONFAISY, C; HEMING, N; URIEN, S et al.Réanimation (Paris. 2001). 2013, Vol 22, Num 4, pp 358-365, issn 1624-0693, 8 p.Article

Effect of alpha-1-acid-glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in ratsURIEN, S; MORIN, D; TILLEMENT, J. P et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 248, Num 2, pp 781-785, issn 0022-3565Article

FIXATION DES MEDICAMENTS SUR LES PROTEINES PLASMATIQUESTILLEMENT JP; HOUIN G; ZINI R et al.1983; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1983; VOL. 59; NO 18; PP. 1413-1422; BIBL. 26 REF.Article

The binding of aryl carboxylic acid derivatives to human serum albumin ― a structure-activity studyURIEN, S; D'ATHIS, P; TILLEMENT, J.-P et al.Biochemical pharmacology. 1984, Vol 33, Num 14, pp 2283-2289, issn 0006-2952Article

Pharmacokinetic modelling of total and unbound plasma carboplatin: a population study in 75 childrenURIEN, S; DOZ, F; NAMOUNI, F et al.International journal of clinical pharmacology and therapeutics. 2002, Vol 40, Num 6, pp 270-278, issn 0946-1965Article

Les transferts des médicaments à travers la barrière hématoencéphalique: mécanismes, évaluations, modélisations, effets des liaisons sanguines = Drug transfer through the blood-brain barrier: mechanisms, estimations, pharmacokinetic models and effects of plasma protein bindingJolliet-Riant Jolliet, Pascale; Urien, S.1995, 278 p.Thesis

Population Pharmacokinetics ofTenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)HIRT, D; URIEN, S; LEANG, S. K et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 2, pp 182-189, issn 0009-9236, 8 p.Article

Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to ratsBERTELLI, A. A. E; GIOVANNINI, L; STRADI, R et al.Drugs under experimental and clinical research. 1998, Vol 24, Num 1, pp 51-55, issn 0378-6501Article

Comparative serum protein binding of anthracycline derivativesCHASSANY, O; URIEN, S; CLAUDEPIERRE, P et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 6, pp 571-573, issn 0344-5704Article

Comparison of the uptake of retinoids 13-cis-retinoic acid and Ro 13-6298 delivered to HL-60 cells by serum albumin or low-density lipoproteinMOUAWAD, R; URIEN, S; SOUBRANE, C et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 2, pp 198-201, issn 0344-5704Article

Docetaxel serum protein binding with high affinity to alpha-acid glycoproteinURIEN, S; BARRE, J; MORIN, C et al.Investigational new drugs. 1996, Vol 14, Num 2, pp 147-151, issn 0167-6997Article

Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cellsLEBARGY, F; KHALID BENHAMMOU; MORIN, D et al.American journal of respiratory and critical care medicine. 1996, Vol 153, Num 3, pp 1056-1063, issn 1073-449XArticle

Binding of retinoid analogues to albumin and lipoproteins of human plasmaURIEN, S; CLAUDEPIERRE, P; NGUYEN, P et al.International journal of clinical pharmacology research. 1994, Vol 14, Num 4, pp 115-118, issn 0251-1649Article

5-Methoxypsoralen binding to proteins: influence of drugs used in PUVA therapyMURET, P; MAKKI, S; URIEN, S et al.EJD. European journal of dermatology. 1993, Vol 3, Num 4, pp 322-323, issn 1167-1122Article

pH-dependence of warfarin binding to α₁-acid glycoprotein (orosomucoid)URIEN, S; BREE, F; TESTA, B et al.Biochemical journal (London. 1984). 1993, Vol 289, pp 767-770, issn 0264-6021, 3Article

Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionCALES, P; CAILLAU, H; CRAMBES, O et al.Journal of hepatology. 1993, Vol 19, Num 1, pp 43-50, issn 0168-8278Article

Pharmacological profile of binedaline, a new antidepressant drugMORIN, D; ZINI, R; URIEN, S et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 249, Num 1, pp 288-296, issn 0022-3565Article

Comparison of different methods for lysing whole blood to measure cyclosporin A by radioimmunuoassayHAMBERGER, C; BARRE, J; URIEN, S et al.Therapeutic drug monitoring. 1988, Vol 10, Num 4, issn 0163-4356, 501Article

Serum binding of indapamide in health and disease: primary role of α1-acid glycoproteinURIEN, S; MORIN, D; D'ATHIS, P et al.Journal of clinical pharmacology. 1988, Vol 28, Num 5, pp 458-462, issn 0091-2700Article

Plasma protein binding and erythrocyte partitioning of nicardipine in vitroURIEN, S; ALBENGRES, E; COMTE, A et al.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 5, pp 891-898, issn 0160-2446Article

Pharmacokinetics and exposure―effect relationships of capecitabine in elderly patients with breast or colorectal cancerDAHER ABDI, Z; LAVAU-DENES, S; PREMAUD, A et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1285-1293, issn 0344-5704, 9 p.Article